DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hye Soon Won | - |
dc.contributor.author | Jee Won Lee | - |
dc.contributor.author | In Ho Kim | - |
dc.contributor.author | Young Hoon Park | - |
dc.date.accessioned | 2017-04-19T08:57:29Z | - |
dc.date.available | 2017-04-19T08:57:29Z | - |
dc.date.issued | 2000 | - |
dc.identifier.issn | 1226-8372 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/5270 | - |
dc.description.abstract | Simple procedures have been devised for purifying recombinant human interleukin-2 (hIL-2), which was expressed in Escherichia coli using sequences of glucagon molecules and enterokinase cleavage site as an N-terminus fusion partner. The insoluble aggregates of recombinant fusion protein produced in E. coli cytoplasm were easily dissolved by simple alkaline pH shift (8→12→8). Following enterokinase cleavage, the recombinant hIL-2 was finally purified by one-step reversed-phase HPLC with high purity. The ease and high efficiency of this simple purification process seem to mainly result from the role of used glucagon fusion partner, which could be applied to the production of other therapeutically important proteins. | - |
dc.publisher | Springer | - |
dc.title | Simple purification of Escherichia coli-derived recombinant human interleukin-2 expressed with N-terminus fusion of glucagon | - |
dc.title.alternative | Simple purification of Escherichia coli-derived recombinant human interleukin-2 expressed with N-terminus fusion of glucagon | - |
dc.type | Article | - |
dc.citation.title | Biotechnology and Bioprocess Engineering | - |
dc.citation.number | 1 | - |
dc.citation.endPage | 16 | - |
dc.citation.startPage | 13 | - |
dc.citation.volume | 5 | - |
dc.contributor.affiliatedAuthor | Jee Won Lee | - |
dc.contributor.affiliatedAuthor | Young Hoon Park | - |
dc.contributor.alternativeName | 원혜순 | - |
dc.contributor.alternativeName | 이지원 | - |
dc.contributor.alternativeName | 김인호 | - |
dc.contributor.alternativeName | 박영훈 | - |
dc.identifier.bibliographicCitation | Biotechnology and Bioprocess Engineering, vol. 5, no. 1, pp. 13-16 | - |
dc.identifier.doi | 10.1007/BF02932346 | - |
dc.subject.keyword | human interleukin-2 | - |
dc.subject.keyword | glucagon | - |
dc.subject.keyword | N-terminus fusion | - |
dc.subject.keyword | purification process | - |
dc.subject.local | human interleukin-2 (IL-2) | - |
dc.subject.local | human interleukin-2 | - |
dc.subject.local | Human interleukin-2 | - |
dc.subject.local | Glucagon | - |
dc.subject.local | glucagon | - |
dc.subject.local | N-terminus fusion | - |
dc.subject.local | purification process | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.